Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Gómez Junyent, Joan ^a   Garcia Vidal, Carolina ^a,b   Viasus, Diego ^a,b   Millat Martínez, Pere ^a   Simonetti, Antonella ^a   Salud Santos, Ma ^a   Ardanuy, Carmen ^a   Dorca, Jordi ^a,b   Carratalà, Jordi ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; RISK FACTOR; AGE; COMMUNITY-ACQUIRED INFECTIONS; COMPLICATION; MIDDLE AGED; PNEUMONIA; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84940327879     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105854     Document Type: Article

References (43)

1. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
2. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, et al. (2007) International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. The Lancet 370: 741-750. (Pubitemid 47321907)
3. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, et al. (2006) Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 27: 188-207. (Pubitemid 43092683)
4. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, et al. (2006) Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 27: 397-412. (Pubitemid 43180921)
5. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, et al. (2005) Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 366: 1875-1881. (Pubitemid 41690116)
6. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, et al. (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 Suppl 2: S27-72. (Pubitemid 46290553)
7. Holguin F, Folch E, Redd SC, Mannino DM (2005) Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 128: 2005-2011. (Pubitemid 41507534)
8. Hogg JC (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364: 709-721.
9. Barnes PJ, Shapiro SD, Pauwels RA (2003) Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22: 672-688. (Pubitemid 37258549)
10. Crisafulli E, Menendez R, Huerta A, Martinez R, Montull B, et al. (2013) Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD. Chest 143: 1009-1017.
11. Calbo E, Valdes E, Ochoa de Echaguen A, Fleites A, Molinos L, et al. (2009) Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected. Eur J Clin Microbiol Infect Dis 28: 971-976.
12. Liapikou A, Polverino E, Ewig S, Cilloniz C, Marcos MA, et al. (2012) Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur Respir J 39: 855-861.
13. Merino-Sanchez M, Alfageme-Michavila I, Reyes-Nunez N, Lima-Alvarez J (2005) Prognosis in patients with pneumonia and chronic obstructive pulmonary disease. Arch Bronconeumol 41: 607-611. (Pubitemid 43041489)
14. Molinos L, Clemente MG, Miranda B, Alvarez C, del Busto B, et al. (2009) Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect 58: 417-424.
15. Mullerova H, Chigbo C, Hagan GW, Woodhead MA, Miravitlles M, et al. (2012) The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Respir Med 106: 1124-1133.
16. Pifarre R, Falguera M, Vicente-de-Vera C, Nogues A (2007) Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med 101: 2139-2144. (Pubitemid 47324242)
17. Rello J, Rodriguez A, Torres A, Roig J, Sole-Violan J, et al. (2006) Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 27: 1210-1216. (Pubitemid 44914306)
18. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A (2006) COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 28: 346-351. (Pubitemid 44914234)
19. Sellares J, Lopez-Giraldo A, Lucena C, Cilloniz C, Amaro R, et al. (2013) Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia. Am J Respir Crit Care Med 187: 1241-1248.
20. Snijders D, van der Eerden M, de Graaff C, Boersma W (2010) The influence of COPD on mortality and severity scoring in community-acquired pneumonia. Respiration 79: 46-53.
21. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, et al. (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336: 243-250. (Pubitemid 27044625)
22. (2013) Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Updated 2013.
23. Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, et al. (1998) Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. Jama 279: 1452-1457. (Pubitemid 28228202)
24. Gutierrez F, Masia M, Rodriguez JC, Mirete C, Soldan B, et al. (2005) Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect 11: 788-800. (Pubitemid 41341711)
25. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, et al. (1998) Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 113: 1542-1548. (Pubitemid 28307157)
26. Garcia-Vidal C, Almagro P, Romani V, Rodriguez-Carballeira M, Cuchi E, et al. (2009) Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J 34: 1072-1078.
27. Garcia-Vidal C, Fernandez-Sabe N, Carratala J, Diaz V, Verdaguer R, et al. (2008) Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 32: 733-739.
28. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, et al. (2012) Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 125: 773-781.
29. Garcia-Vidal C, Carratala J, Diaz V, Dorca J, Verdaguer R, et al. (2009) [Factors associated with prolonged hospital stay in community-acquired pneumonia]. Enferm Infecc Microbiol Clin 27: 160-164.
30. Garcia-Vidal C, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R, et al. (2009) Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect 15: 1033-1038.
31. Ramirez J, Aliberti S, Mirsaeidi M, Peyrani P, Filardo G, et al. (2008) Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 47: 182-187. (Pubitemid 351920618)
32. Garcia-Vidal C, Calbo E, Pascual V, Ferrer C, Quintana S, et al. (2007) Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J 30: 951-956. (Pubitemid 351194800)
33. Crim C, Calverley PM, Anderson JA, Celli B, Ferguson GT, et al. (2009) Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 34: 641-647.
34. Chen D, Restrepo MI, Fine MJ, Pugh MJ, Anzueto A, et al. (2011) Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am J Respir Crit Care Med 184: 312-316.
35. Ernst P, Gonzalez AV, Brassard P, Suissa S (2007) Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 176: 162-166. (Pubitemid 47057852)
36. Malo de Molina R, Mortensen EM, Restrepo MI, Copeland LA, Pugh MJ, et al. (2010) Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia. Eur Respir J 36: 751-757.
37. Centers for Disease Control and Prevention (CDC) (1997) Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 46: 1-24.
38. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, et al. (2003) Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 348: 1747-1755. (Pubitemid 36514705)
39. Moberley S, Holden J, Tatham DP, Andrews RM (2013) Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 1: Cd000422.
40. Mykietiuk A, Carratala J, Dominguez A, Manzur A, Fernandez-Sabe N, et al. (2006) Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur - J Clin Microbiol Infect Dis 25: 457-462. (Pubitemid 44078598)
41. Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, et al. (2006) Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 42: 1093-1101.
42. Johnstone J, Marrie TJ, Eurich DT, Majumdar SR (2007) Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 167: 1938-1943. (Pubitemid 47606632)
43. Nichol KL, Baken L, Wuorenma J, Nelson A (1999) The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 159: 2437-2442. (Pubitemid 29526772)